Bimeda

Butagran Equi 200mg/g Oral powder for Horses

Price range: £0.75 through £67.49

Legal category : POM-V

Butagran for horses contains Phenylbutazone (“Bute”) which is a an anti-inflammatory & analgesic (pain relief) drug. It is Vanilla flavour, so is more palatable to horses than other alternatives.

A veterinary prescription is required to purchase this medication.

Packaging

Clear

Prescriptions

I understand a valid veterinary prescription is required for this prescription-only medicine *
I will provide my prescription by: *
Email prescription *

Please e-mail your prescription to [email protected]
Post prescription *

Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA

Vet will send directly *

Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below

Your vet practice: *
Prescription *

Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf
Animal name(s) *

Product total

Options total

Grand total

View POM Delivery & Returns

Secure Checkout with

Accredited Retailer

Butagran Oral Powder is supplied in sachets, each containing 1g of Phenylbutazone ("bute"), a drug from the NSAID group (Non Steroidal Anti-inflammatory Drug). It is used for the treatment of lameness in horses, for example due to acute & chronic laminitis osteoarthritic conditions, bursitis & carpitis.

It can also be used post-surgery to relieve soft tissue swelling.

It is also antipyretic (lowers fevers). It works by inhibiting the body from synthesising prostaglandins, which facilitate pain & trigger inflammatory processes & pyrogens (substances which cause a fever).

Supplied in packs of 100.

Butagran for horses requires a prescription from your vet & will only be dispatched once we receive this prescription.

Warnings & Contraindications- Do not give to horses with known hypersensitivity to Phenylbutazone. Do not give to horses with heart, liver or kidney disease; gastric ulceration or blood disorders.Do not give within 24 hours of giving another NSAID or corticosteroid, please contact your vet or our helpline if unsure.

Pregnancy & Lactation- Seek advice from your vet for use during pregnancy & lactation. Use not recommended during first trimester of pregnancy.

Passport Requirements- This medication cannot be used in horses intended for human consumption. Your vet must have signed Section 9 of your horse's passport (or Section 2 for passports issued after 1st January 2016).

Product Description

Butagran Oral Powder is supplied in sachets, each containing 1g of Phenylbutazone (“bute”), a drug from the NSAID group (Non Steroidal Anti-inflammatory Drug). It is used for the treatment of lameness in horses, for example due to acute & chronic laminitis osteoarthritic conditions, bursitis & carpitis.

It can also be used post-surgery to relieve soft tissue swelling.

It is also antipyretic (lowers fevers). It works by inhibiting the body from synthesising prostaglandins, which facilitate pain & trigger inflammatory processes & pyrogens (substances which cause a fever).

Supplied in packs of 100.

Butagran for horses requires a prescription from your vet & will only be dispatched once we receive this prescription.

Warnings & Contraindications- Do not give to horses with known hypersensitivity to Phenylbutazone. Do not give to horses with heart, liver or kidney disease; gastric ulceration or blood disorders.Do not give within 24 hours of giving another NSAID or corticosteroid, please contact your vet or our helpline if unsure.

Pregnancy & Lactation- Seek advice from your vet for use during pregnancy & lactation. Use not recommended during first trimester of pregnancy.

Passport Requirements- This medication cannot be used in horses intended for human consumption. Your vet must have signed Section 9 of your horse’s passport (or Section 2 for passports issued after 1st January 2016).